Company Presentation
Ethris
| Country: | Germany |
| Category: | Clinical Stage Biotech Company |
| Room: | Rio |
| Date: | 25.04.2023 |
| Time: | 13:30-13:45 |
| Website: | https://www.ethris.com/ |
| Speaker: | Carsten Rudolph, CEO |
Company profile
Ethris is developing mRNA-based therapeutics and vaccines to treat patients with (rare) respiratory disorders and infectious diseases.
Ethris’ novel, proprietary technology platform consisting of SNIM RNA , SNaP LNP and Stabilizer preventing LNP aggregation which affords multi-route, multi-cargo delivery options for intramuscular, inhaled or nasal administration and suitable for several genetic medicine payloads including mRNA and gene editing technologies
